Lactobacillus improves infant reflux symptomsEffect of Lactobacillus reuteri NCIMB 30351 drops on symptoms of infantile functional gastrointestinal disorders and gut microbiota in early infants: Results from a randomized, placebo-controlled clinical trial.
We explored the impact of Lactobacillus reuteri NCIMB 30351 on common gastrointestinal issues in infants, focusing on gastroesophageal reflux. Conducted as a randomized and placebo-controlled trial, 90 infants received either the probiotic drops or a placebo for 25 days.
Our findings revealed that the probiotic significantly reduced regurgitation and crying times while increasing bowel movements in infants with constipation. However, it didn't show strong effects on diarrhea. Overall, Lactobacillus reuteri appears to be a safe and effective option for managing reflux and colic in newborns.
Read More
Lactobacillus effectively reduces refluxEffect of a Partially Hydrolysed Whey Infant Formula Supplemented with Starch and Lactobacillus reuteri DSM 17938 on Regurgitation and Gastric Motility.
This double-blind, randomized controlled trial explored the use of a specialized infant formula with Lactobacillus reuteri DSM 17938 to reduce functional regurgitation (FR) in infants. We found that infants consuming the test formula experienced a significant decrease in regurgitation frequency—from an average of 7.4 to 2.6 regurgitations per day—compared to smaller changes in the control group. Additionally, gastric emptying improved more in the test group, suggesting this combination could offer benefits for managing FR in infants.
Read More
Probiotic supplement reduces GERD symptomsEfficacy of a Food Supplement Containing LA14, Peptides, and a Multivitamin Complex in Improving Gastroesophageal Reflux Disease-Related Outcomes and Quality of Life of Subjects Showing Mild-to-Moderate Gastroesophageal Reflux Disease.
We explored the effects of a dietary supplement containing probiotics, bioactive peptides, and vitamins on heartburn and quality of life in individuals with mild-to-moderate gastroesophageal reflux disease (GERD). In a well-structured, randomized, double-blind, placebo-controlled study involving 56 adults over 28 days, we noted a significant reduction in heartburn frequency and severity in those taking the supplement compared to the placebo group.
Participants also reported taking fewer over-the-counter medications and recognized improvements in their overall quality of life.
Read More
Lactobacillus reduces heartburn symptomsBeneficial Effect of Heat-Killed Lactic Acid Bacterium No. 1088 on Temporal Gastroesophageal Reflux-Related Symptoms in Healthy Volunteers: A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study.
We investigated the impact of heat-killed Lactobacillus No. 1088 on gastroesophageal reflux symptoms in healthy volunteers. In a carefully designed study, 120 participants were randomly assigned to either the Lactobacillus group or placebo for six weeks.
We observed that those taking Lactobacillus experienced significant improvement in heartburn symptoms compared to the placebo group. Overall, it seems that this lactobacillus strain could offer some relief for occasional heartburn in healthy individuals without severe side effects.
Read More
Impact of fermented soy on refluxProfiling of Metabolites in a Fermented Soy Dietary Supplement Reinforces its Role in the Management of Intestinal Inflammation.
We explored how a fermented soy product called GAD, made with Lactobacillus delbrueckii, impacts gastroesophageal reflux and peptic ulcers. Using advanced techniques like H NMR spectroscopy, we identified changes in the compounds released during fermentation, including anti-inflammatory molecules.
These changes point to how GAD might reduce inflammation in the stomach, potentially linking its effects to symptom improvement. However, while we noted significant changes in the metabolite profile, further research is necessary to fully assess GAD's effectiveness in managing reflux symptoms.
Read More